Reglicem is an innovative nutraceutical product developed by Biofarma Group, able to reduce IFG and IGT values in patients with prediabetes conditions.
- Curcuma longa is effective in reducing glycemia and hyperlipidaemia and improves insulin sensitivity
- Berberis vulgaris promotes glucose and HbA1c lowering in patients with diabetes type II
- Lagerstroemia speciosa exhibits hypoglycaemic, antihyperlipidemic and antioxidant activities.
- Inositol is effective in decreasing the level of insulin resistance
- Chromium acts as an ‘insulin-sensitizing’ agent
This Techincal Paper is from Biofarma.
NUTRITION & HEALTH NEWS
One Health: Nutrition and physical activity interventions created to get public in shape
15 Apr 2024 --- In the last few years, researchers from the University of Illinois, US, have been working on behavioral health intervention programs to improve nutrition and physical activity levels in the US using the One Health... Read More
NUTRITION & HEALTH NEWS
L-Nutra calls to add fasting-mimicking nutrition technology to diabetes management
09 Apr 2024 --- A clinical trial by nutri-technology company L-Nutra suggests that a fasting-mimicking diet (FMD) may provide a better intervention method for type 2 diabetes than standard care alone. The study found positive... Read More
NUTRITION & HEALTH NEWS
Holy cow: Scientists breed world’s first transgenic bovine able to produce human insulin in milk
18 Mar 2024 --- Researchers have successfully bred the first-ever transgenic cow capable of producing human insulin in her milk in a novel method that could help solve insulin shortages. And now the findings of the study provide... Read More
BUSINESS NEWS
08 Mar 2024 --- This week in nutrition news, the US Food and Drug Administration (FDA) unveiled its guidance for new dietary ingredient (NDI) notifications. Also, the Council for Responsible Nutrition (CRN) and Radicle Science... Read More
NUTRITION & HEALTH NEWS
Danone health director discusses new FDA health claim linking yogurt to lower type 2 diabetes risk
07 Mar 2024 --- The US Food and Drug Administration (FDA) has announced its first-ever qualified health claim for yogurt, responding to a petition submitted by Danone North America. The new health claim recognizes the link... Read More
21 Mar 2024 --- At Natural Products Expo West (NPEW), we met up with Dr. Thais Cesar and Doug Lynch from Ingredients by Nature to discuss the latest experimental research on the company’s Eriomin, a multi-patented citrus flavonoid blend, highlighting its antioxidant activity and its potential to support liver function. They dive into the ingredient’s role in boosting Glucagon-Like Peptide-1 (GLP-1) levels and the mechanism of action between popular anti-obesity drugs.
Ingredia’s Pep2Dia addresses prediabetes with whey protein hydrolysate
14 Sep 2023 --- Ingredia’s patented ingredient from cow’s milk is positioned to help consumers control their glycemic health. The clinically tested whey protein hydrolysate is seeing increased interest on the market as type 2 diabetes cases are on the rise, reports the company. Laurie-Anne Giacomini, product manager at Ingredia, explains how the ingredient’s “inhibiting effect” can help consumers achieve more stable blood sugar levels.
The launch of a type 2 diabetes prevention nutritional
09 May 2019 --- Ingredia Nutritional has debuted Pep2Dia at Vitafoods Europe 2019 an ingredient to help prevent Type 2 diabetes. The dairy bioactive is the result of extensive research and collaboration between Ingredia’s scientists and LIENSs-CNRS La Rochelle University in France. Pep2Dia has proven efficacy on glycemia after meals. Pre-clinical and clinical studies support Pep2Dia’s action to reduce postprandial glycemia with a significant effect versus a placebo. Aurore Chemineau discusses one of this year’s show highlights from the Geneva event.
Marine microalgae for metabolic disease prevention
01 Apr 2019 --- Goncalo Real, Communications Director at Algalenic Labs spoke to NutritionInsight at Nutraceuticals Europe 2019 in Madrid, Spain on the company's microalgae ingredients. “We produce chlorella in Porto Santo island, where the ingredient gets all the purity of the Atlantic ocean,” Real says. “We use this ingredient to produce health supplements and supplements targeting sports nutrition. We also have products like shakes and protein powders, which all have microalgae as the base ingredient.” The major area that Real sees a lot of consumer interest in is related to metabolic disease and anything to do with diabetes, heart health and sugar or cholesterol levels, which are the areas Algalenic Labs' ingredients cover.
18 Oct 2018 --- Digestive health was another key theme a key theme at Vitafoods Asia. The role for probiotics and prebiotics in addressing metabolic health syndrome remains on the rise. “Some of the most recent studies focused on metabolic health and the effect on things like diabetes, weight management and more. That is where we see a lot of interest. A recent study involved more than 400 studies given probiotics for more than 6 months. If you look at the build-up of fat mass, you see a significant loss in both the probiotic group and another where probiotics are combined with polydextrose,” says Anders Henriksson of DuPont Health & Nutrition, who presented at the Vitafoods Asia conference on this study.